Clinical Trials Logo

Clinical Trial Summary

Multicenter, randomized, evaluator-blinded clinical trial compared to Prednisolone acetate, 1% in the treatment of inflammation and pain after cataract surgery in pediatric population. This study will assess the safety of Clobetasol propionate ophthalmic nanoemulsion, 0.05% to that of Prednisolone acetate, 1% when administering one drop four times a day (QID) for 14 days followed by a tapering period of 14 days after cataract surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05724446
Study type Interventional
Source Salvat
Contact Enrique Jimenez
Phone +34 933946400
Email ejimenez@svt.com
Status Recruiting
Phase Phase 3
Start date December 12, 2022
Completion date August 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03016156 - Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma N/A
Completed NCT06396156 - Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support. N/A
Recruiting NCT03812640 - Nylon Verus Polyglactin Corneal Suture in Pediatric Cataract Surgery N/A